2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Use of Rucaparib (Rubraca®) and Indications
Use of Rucaparib (Rubraca®) and Indications
About this PQI
The purpose of this PQI is to discuss the various indications and management of rucaparib (Rubraca®).

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Last Updated: 10/18/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Last Updated: 10/18/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Last Updated: 10/18/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Last Updated: 10/18/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 10/18/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 10/18/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 10/18/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 10/18/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Mirtevuximab Soravtansine
Last Updated: 10/18/2025
Trastuzumab
Last Updated: 10/18/2025
Rucaparib
Last Updated: 10/18/2025
Paclitaxel
Last Updated: 10/18/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Mirtevuximab Soravtansine
Last Updated: 10/18/2025
Trastuzumab
Last Updated: 10/18/2025
Rucaparib
Last Updated: 10/18/2025
Paclitaxel
Last Updated: 10/18/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Mirtevuximab Soravtansine
Last Updated: 10/18/2025
Trastuzumab
Last Updated: 10/18/2025
Rucaparib
Last Updated: 10/18/2025
Paclitaxel
Last Updated: 10/18/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Talazoparib
Last Updated: 10/18/2025
Rucaparib
Last Updated: 10/18/2025
Relugolix
Last Updated: 10/18/2025
Olaparib
Last Updated: 10/18/2025
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 10/18/2025
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 10/18/2025
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 10/18/2025
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 10/18/2025
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 10/18/2025
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 10/18/2025
PQI in Action
Treatment Discussion Guides
Patient Education Sheet
Patient Education Sheet
PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/18/2025
Nirogacestat (Ogsiveo): Treatment Discussion Guide
Last Updated: 10/18/2025
Vorasidenib
Last Updated: 10/18/2025
Encorafenib and Binimetinib
Last Updated: 10/18/2025